PT917471E - Tratamento e diagnostico de infeccoes por cocci gram-positivo - Google Patents

Tratamento e diagnostico de infeccoes por cocci gram-positivo

Info

Publication number
PT917471E
PT917471E PT97930642T PT97930642T PT917471E PT 917471 E PT917471 E PT 917471E PT 97930642 T PT97930642 T PT 97930642T PT 97930642 T PT97930642 T PT 97930642T PT 917471 E PT917471 E PT 917471E
Authority
PT
Portugal
Prior art keywords
diagnosis
methods
treatment
same
agents specific
Prior art date
Application number
PT97930642T
Other languages
English (en)
Inventor
Burnie James Peter
Matthews Ruth Christine
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Publication of PT917471E publication Critical patent/PT917471E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97930642T 1996-07-06 1997-07-07 Tratamento e diagnostico de infeccoes por cocci gram-positivo PT917471E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9614274.0A GB9614274D0 (en) 1996-07-06 1996-07-06 Treatment and diagnosis of infections of gram positive cocci

Publications (1)

Publication Number Publication Date
PT917471E true PT917471E (pt) 2005-07-29

Family

ID=10796521

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97930642T PT917471E (pt) 1996-07-06 1997-07-07 Tratamento e diagnostico de infeccoes por cocci gram-positivo

Country Status (13)

Country Link
US (2) US6544516B1 (pt)
EP (1) EP0917471B1 (pt)
JP (1) JP2001505534A (pt)
AT (1) ATE293456T1 (pt)
AU (1) AU717332B2 (pt)
CA (1) CA2259141C (pt)
DE (1) DE69733067T2 (pt)
DK (1) DK0917471T3 (pt)
ES (1) ES2238080T3 (pt)
GB (1) GB9614274D0 (pt)
NZ (1) NZ332991A (pt)
PT (1) PT917471E (pt)
WO (1) WO1998001154A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
GB9806762D0 (en) 1998-03-31 1998-05-27 Neutec Pharma Plc Treatment and diagnosis of staphylococcal infections
EP1624064A3 (en) * 1998-07-27 2006-05-10 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae
EP1397502A2 (en) * 2001-01-17 2004-03-17 Avestha Gengraine Technologies PVT Ltd Dna sequencing of abc transporter or multi drug resistant protein for better environment stress tolerant crops
EP1443957A4 (en) * 2001-05-08 2005-10-12 Texas A & M Univ Sys SURFACE PROTEINS FROM GRAM POSITIVE BACTERIA COMPRISING HIGHLY PRESERVED PATTERNS AND ANTIBODIES RECOGNIZING THESE REASONS
GB0127983D0 (en) * 2001-11-22 2002-01-16 Neutec Pharma Plc Treatment of micro-organism infection
US8729013B2 (en) 2004-08-26 2014-05-20 The University Of Western Ontario Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
EP2450053B1 (en) * 2010-11-05 2016-06-15 Universitätsklinikum Freiburg Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis
CA2879272A1 (en) 2012-07-16 2014-01-23 Robert G.K. DONALD Saccharides and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
WO1993006247A1 (en) * 1991-09-16 1993-04-01 Abbott Laboratories Hepatitis c assay
GB9401689D0 (en) * 1994-01-28 1994-03-23 Univ Manchester Diagnosis and treatment of endocarditis

Also Published As

Publication number Publication date
DE69733067D1 (de) 2005-05-25
CA2259141C (en) 2007-12-11
WO1998001154A2 (en) 1998-01-15
WO1998001154A3 (en) 1998-06-25
CA2259141A1 (en) 1998-01-15
EP0917471B1 (en) 2005-04-20
ES2238080T3 (es) 2005-08-16
US20030119101A1 (en) 2003-06-26
DE69733067T2 (de) 2006-01-26
EP0917471A2 (en) 1999-05-26
DK0917471T3 (da) 2005-06-06
AU3452297A (en) 1998-02-02
NZ332991A (en) 1999-06-29
US6544516B1 (en) 2003-04-08
AU717332B2 (en) 2000-03-23
ATE293456T1 (de) 2005-05-15
US6881410B2 (en) 2005-04-19
JP2001505534A (ja) 2001-04-24
GB9614274D0 (en) 1996-09-04

Similar Documents

Publication Publication Date Title
TR200102497T2 (tr) Yeni streptococcus antijenleri
UY26783A1 (es) Antígenos de estreptococo.
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
AP2000001886A0 (en) Group B streptococcus antigens.
ATE461938T1 (de) Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung
CY1108765T1 (el) ΑΓΩΓΗ ME ΑΝΤΙΣΩΜΑΤΑ ANTI-ErbB2
WO1999051748A3 (en) Fusion proteins of mycobacterium tuberculosis antigens and their uses
WO2003039462A3 (en) B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
CY1109868T1 (el) Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c
PT917471E (pt) Tratamento e diagnostico de infeccoes por cocci gram-positivo
GB9806762D0 (en) Treatment and diagnosis of staphylococcal infections
WO2004003155A3 (en) Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
IL159479A0 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
WO2007118077A3 (en) Mycobacterial catalase-peroxidase in the diagnosis and treatment of sarcoidosis
GB9715177D0 (en) Medicament
EP1219635A3 (en) Chlamydia pneumoniae antigenes
EP1950302A3 (en) Streptococcus antigens